Abstract:Abstract OBJECTIVES Restrictive cardiomyopathy is rare and is generally associated with worse clinical outcomes compared to other cardiomyopathies. Ventricular assist device support for these children is seldom applied and often hampered by the surgical difficulties. METHODS All paediatric (<19 years) patients with a restricted cardiomyopathy supported by a ventricular assist device from the EUROMACS database were included and compared to patients with a dilated cardiomyopathy (retrospective database analyses). Participating centres were retrospectively contacted to provide additional detailed echo and Swan Ganz measurements to analyse the effect of ventricular assist device support on pulmonary artery pressure and right ventricular function. RESULTS Forty-four paediatric ventricular assist device-supported patients diagnosed with restricted cardiomyopathy were included, with a median age at implantation of 5.0 years. Twenty-six of the 44 patient with a restricted cardiomyopathy survived to transplantation (59.1%), 16 died (36.4%) and 2 are still on ongoing VAD support (4.5%) after a median duration of support of 95.5 days (IQR 33.3–217.8). Transplantation probability after 1 and 2 years of ventricular assist device support in patients with a restricted cardiomyopathy were comparable to patients with a dilated cardiomyopathy (52.3% vs 51.4% and 59.5% vs 60.1%, p = 0.868). However, mortality probability was higher in the restricted cardiomyopathy cohort (35.8% vs 17.0% and 35.8% vs 19.0%, p = 0.005). Adverse event rates were high (CVA in 31.8%, pump thrombosis in 29.5%, major bleeding 25.0%, eventual biventricular support in 59.1%). In the atrially cannulated group, CVA and pump thrombosis occurred in twice as much patients (21.1% vs 40.0%, p = 0.595 and 15.8% vs 40.0%, p = 0.464; probably non-significant due to the small numbers). Pulmonary arterial pressures improved after implantation of a ventricular assist device, and six patients who were initially labelled as ineligible due to pulmonary hypertension could eventually be transplanted. CONCLUSIONS Ventricular assist device support in children with a restricted cardiomyopathy is rarely performed. Mortality and adverse event rates are high. On the other hand, survival to cardiac transplantation was 59.1% with all patients surviving the first 30 days after cardiac transplantation. Pulmonary arterial pressures improved while on support, potentially making cardiac transplantation a viable option for previously ineligible children.

Evaluation of cardiac arrhythmia in pediatric patients with Left Ventricular Assist Device (L-VAD)

Left Ventricular Assist Device in Heart Failure Due to Pediatric Primary Cardiomyopathy

Evaluation of thrombosis and bleeding events in the children with left ventricular assist device (L-VAD)

Pediatric ventricular assist device therapy for advanced heart failure-Hong Kong experience

Clinical features and arrhythmic complications of patients with pediatric-onset arrhythmogenic right ventricular dysplasia

Ventricular assist device support in paediatric patients with restrictive cardiomyopathy - Clinical outcomes and haemodynamics

Ventricular Arrhythmias in Left Ventricular Assist Device Patients—Current Diagnostic and Therapeutic Considerations

The Clinical Management of Ventricular Assist Device

Clinical Application and Choice of Mechanical Circulatory Support Devices in Children

Development Status of Ventricular Assist Devices in Children

Current status and future directions in pediatric ventricular assist device

Clinical Analysis of Diagnose and Treatment in Heart Failure Due to Pediatric Primary Cardiomyopathy

The Influence of Arrhythmias and Metabolic Profile on Inpatient Mortality in Patients with Left Ventricular Assist Devices

Ventricular Arrhythmias and Sudden Cardiac Death in Left Ventricular Assist Device Patients Without Implantable Cardioverter Defibrillators

Short Term Left Ventricular Assistive Device Use in Postoperative Pediatric Patients with Congenital Heart Disease

Arrhythmias in children undergoing orthotopic heart transplantation

Durable left ventricular assist devices in pediatrics: impact of body size on outcomes and size limitations

Development of Antiarrhythmic Therapy-Resistant Ventricular Tachycardia, Ventricular Fibrillation, and Premature Ventricular Contractions in a 15-Year-Old Patient

Left Ventricular Epicardial Pacing Achieved Hyper‐responsiveness in Young Children with Dilated Cardiomyopathy with Left Bundle Branch Block

Outcomes and Complications after Left Ventricular Assist Device Implantation

Echocardiographic Predictors of Ventricular Arrhythmias in Patients With Left Ventricular Assist Devices and Implantable Cardioverter‐Defibrillator